ADC Therapeutics SA
1.22USD
-0.0800 (-6.15%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 20 | 30 | 16 | 18 | 17 | 18 | 18 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -25 | -25 | -18 | -31 | -44 | -28 | -32 | -36 |
| Net Income | -17 | -33 | -6 | -41 | -57 | -39 | -31 | -44 |
| EPS (Diluted) | $-0.11 | $-0.21 | $0.02 | $-0.30 | $-0.50 | $-0.36 | $-0.27 | $-0.42 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)